No Data
No Data
Truist Financial Maintains Autolus Therapeutics(AUTL.US) With Buy Rating
Autolus Therapeutics Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains Overweight on Autolus Therapeutics, Lowers Price Target to $6
Autolus Therapeutics Analyst Ratings
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Flat for Week
A Quick Look at Today's Ratings for Autolus Therapeutics(AUTL.US), With a Forecast Between $6 to $10
blessings u : Thank you for sharing.
Trytosaveabit OP blessings u : you’re welcome![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)